cdk4 glutathione MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation CDK2 and CDK4: Cell Cycle
CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis Competent Conformations, Offering Drug Targets JACS Au Discovery of the GSH responsive Y PROTACs targeting ALK and CDK4 6 as a potential treatment for cancer ScienceDirect Cyclin D CDK4 Disulfide Bond Attenuates Pulmonary Vascular Cell Proliferation Circulation Research Therapeutic potential of CDK4 6 inhibitors in renal cell carcinoma Nature Reviews Urology
Pay in 4 interest-free payments of $6.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10



